SCHEMBL4533401

SCHEMBL4533401

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(C(=N)NO)n4)ncnc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.46
HDAC6 Q9UBN7 2/20 0.46
HTT P42858 2/20 0.43
HDAC2 Q92769 1/20 0.41
HPGD P15428 1/20 0.40
TP53 P04637 2/20 0.39
MAPT P10636 3/20 0.39
TMIGD3 P0DMS9 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
YTHDC1 Q96MU7 1/20 0.39
ADORA2B P29275 1/20 0.39
CCNE2 O96020 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CTSL P07711 2/20 0.38
CCNB2 O95067 1/20 0.38
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNB3 Q8WWL7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4530998 0.90 HDAC1 (0.47) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL4542188 0.88 HDAC1 (0.43) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL4542862 0.87 HTT (0.45) HDAC1HDAC6HTTHPGDTP53
SCHEMBL4534986 0.84 HDAC1 (0.44) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL4539338 0.84 CTSL (0.47) HDAC1HDAC6HTTHPGDTP53
SCHEMBL4539184 0.84 HDAC1 (0.43) HDAC1HDAC6HTTHDAC2HPGD
SCHEMBL3695022 0.84 HDAC1 (0.46) HDAC1HDAC6HTTHPGDMAPT
SCHEMBL4541032 0.82 MAPT (0.47) HDAC1HDAC6HTTHPGDTP53
SCHEMBL4564684 0.81 HDAC1 (0.42) HDAC1HDAC6HTTHPGDTP53
SCHEMBL4539397 0.81 PDE10A (0.41) HDAC1HDAC6HTTHPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed